| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 08/15/2002 | WO2002062298A2 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 08/15/2002 | WO2002062205A2 Methods for diagnosing and treating heart disease |
| 08/15/2002 | WO2002062204A2 Methods for diagnosing and treating heart disease |
| 08/15/2002 | WO2002062134A1 Human sphingosine-1-phosphate phosphatase |
| 08/15/2002 | WO2002046404A9 Schizophrenia-related voltage-gated ion channel gene and protein |
| 08/15/2002 | WO2002032937A3 Neuromedin u delta |
| 08/15/2002 | WO2002018554A3 Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof |
| 08/15/2002 | WO2002002621A3 Mammalian secreted proteins |
| 08/15/2002 | WO2001096875A9 Hcv antigen/antibody combination assay |
| 08/15/2002 | WO2001066753A3 Human genes and gene expression products |
| 08/15/2002 | WO2001066572A9 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 08/15/2002 | WO2001064899A3 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method |
| 08/15/2002 | WO2001040309A9 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 08/15/2002 | WO2001034801A9 Recombinant gelatin in vaccines |
| 08/15/2002 | WO2001034168A9 Inhibition of pathogens by bacillus coagulans strains |
| 08/15/2002 | WO2001032927A3 Tissue specific genes of diagnostic import |
| 08/15/2002 | WO2001019856A3 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 08/15/2002 | WO1999064067A9 Vaccine |
| 08/15/2002 | US20020111472 T1-r ligand iii |
| 08/15/2002 | US20020111470 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 08/15/2002 | US20020111468 Nucleotide sequences coding for the sigD gene |
| 08/15/2002 | US20020111463 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 08/15/2002 | US20020111310 25219, a novel human aminotransferase and uses therefor |
| 08/15/2002 | US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 08/15/2002 | US20020111299 Family of peptides known as xenoxins |
| 08/15/2002 | US20020110907 Apparatus for use in the storage and preservation of pharmaceutical and biological materials |
| 08/15/2002 | US20020110906 Automated imaging and harvesting of colonies on thin film culture devices |
| 08/15/2002 | US20020110897 Nucleotide squences coding preferential operon for use in the generation of an antibiotics and desoamine |
| 08/15/2002 | US20020110895 Nucleotide sequences coding enzymatic polypeptide for use in treatment of thrombosis and in the immune defects |
| 08/15/2002 | US20020110889 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110888 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110885 Methanotrophic carbon metabolism pathway genes and enzymes |
| 08/15/2002 | US20020110883 Novel motor proteins and methods for their use |
| 08/15/2002 | US20020110881 Food flavor additive |
| 08/15/2002 | US20020110879 Nucleotide sequences coding for the ppgK gene |
| 08/15/2002 | US20020110878 Nucleotide sequences which code for the metY gene |
| 08/15/2002 | US20020110876 Method for producing threonine and isoleucine |
| 08/15/2002 | US20020110874 Recombinant production of novel polyketides |
| 08/15/2002 | US20020110873 Process for the production of lipstatin and tetrahydrolipstatin |
| 08/15/2002 | US20020110870 Therapeutic applications for CCR5 chemokine receptors |
| 08/15/2002 | US20020110868 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 08/15/2002 | US20020110866 Nucleotide sequences coding viral capsid protein; for use in the diagnosis, treatment and/or vaccination |
| 08/15/2002 | US20020110865 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses |
| 08/15/2002 | US20020110863 Nucleotide sequences coding enzymatic polypeptide for use as tool genetic engineering |
| 08/15/2002 | US20020110861 Expression vectors for use as tools for controlling gene expression in genetic engineering |
| 08/15/2002 | US20020110860 Chimeric polypeptides for use as gene expression tool in genetic engineering |
| 08/15/2002 | US20020110859 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/15/2002 | US20020110857 Nucleotide sequences coding polypeptide for use in the treatment of fat defects |
| 08/15/2002 | US20020110855 Mammalian secreted proteins |
| 08/15/2002 | US20020110853 Polypeptide; for use in the treatment of tumors |
| 08/15/2002 | US20020110836 PD-L2 molecules: novel PD-1 ligands and uses therefor |
| 08/15/2002 | US20020110805 Peptide for use in the treatment of glomerulonephritis, psoriasis, leukemia, antherosclerosis, autoimmune diseases, inflammatory, arthritic, asthmatic, and fibrotic disorders |
| 08/15/2002 | US20020110550 Using esterase activity enzyme selected from pepper esterase and porcine esterase for protection of plant against phytopathogenic fuigi, protects plant against phytopathogenic fungi by inhibition of fungal appressorium formation |
| 08/15/2002 | US20020110548 Human GDP-mannose 4,6 dehydratase |
| 08/15/2002 | US20020108505 Production process for foodstuff fermenting agents |
| 08/15/2002 | CA2447905A1 Hyperblebbing bacterial strains and use thereof for production of vaccines |
| 08/15/2002 | CA2437717A1 G-protein coupled receptors |
| 08/15/2002 | CA2437596A1 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 08/15/2002 | CA2437577A1 Human sphingosine-1-phosphate phosphatase |
| 08/15/2002 | CA2437573A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437570A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437503A1 Hepatitis b virus treatment |
| 08/15/2002 | CA2437497A1 Lipid-associated molecules |
| 08/15/2002 | CA2437484A1 Ragweed allergens |
| 08/15/2002 | CA2437434A1 Method for identifying compounds modulating reverse cholesterol transport |
| 08/15/2002 | CA2437185A1 Timm8b-related protein |
| 08/15/2002 | CA2436470A1 Intracellular signaling molecules |
| 08/15/2002 | CA2436435A1 Vaccine composition |
| 08/15/2002 | CA2436264A1 Endotoxin binding by lactic acid bacteria and bifidobacteria |
| 08/15/2002 | CA2435814A1 Multi-sample fermentor and method of using same |
| 08/15/2002 | CA2434944A1 Secreted proteins |
| 08/15/2002 | CA2433439A1 Proteins and nucleic acids encoding same |
| 08/14/2002 | EP1231276A1 Method for purifying proteins and/or biomolecule of protein complexes |
| 08/14/2002 | EP1231275A2 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/14/2002 | EP1231274A2 Modified porteinase inhibitors |
| 08/14/2002 | EP1231270A1 Novel protein and dna thereof |
| 08/14/2002 | EP1231268A2 Polyclonal antibody libraries |
| 08/14/2002 | EP1231266A1 Arabidopsis-origin gdp-4-keto-6-deoxy-d-mannose-3,5-epimerase-4-reductase gene |
| 08/14/2002 | EP1231259A2 Transferring materials into cells using porous silicon |
| 08/14/2002 | EP1231217A2 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/14/2002 | EP1230551A2 Methods to identify compounds that modulate neuronal activity |
| 08/14/2002 | EP1230400A1 Degradation of polycyclic aromatic hydrocarbons |
| 08/14/2002 | EP1230379A2 Regulating endogenous inhibitor at atp synthase |
| 08/14/2002 | EP1230371A2 Method for producing recombinant interleucin-8 and interleucin-8 muteins |
| 08/14/2002 | EP1230370A2 Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same |
| 08/14/2002 | EP1230369A2 Polypeptide hormone phosphatonin |
| 08/14/2002 | EP1230368A2 Mammalian receptor proteins; related reagents and methods |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230365A2 Bt toxin receptors from lepidopteran insects and methods of use |
| 08/14/2002 | EP1230364A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230357A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 08/14/2002 | EP1230356A2 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 08/14/2002 | EP1230351A1 Fungamyl-like alpha-amylase variants |
| 08/14/2002 | EP1230350A1 Site-directed mutagenesis of escherichia coli phytase |
| 08/14/2002 | EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/14/2002 | EP1230271A1 Hedgehog fusion proteins and uses |
| 08/14/2002 | EP1230269A2 Antibody diversity generation |